Purified anti-β-Amyloid, 1-16 Antibody (Previously Covance catalog# SIG-39320)

Pricing & Availability
Clone
6E10 (See other available formats)
Other Names
AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2, Amyloid beta A4 protein, preA4, protease, peptidase nexin-II, beta-amyloid peptide, alzheimer disease amyloid protein, cerebral vascular amyloid peptide, APP, Amyloid Precursor Protein
Previously
Signet Catalog# 9320-02
Signet Catalog# 9320-05
Signet Catalog# 9320-10
Covance Catalog# SIG-39320
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
A_6E10_PURE_betaAmyloid_1-16_WB_050818
Western blot of purified anti-β-amyloid, 1-16 antibody (clone 6E10). Lane 1: Molecular weight marker; Lane 2: 50 ng of the human Aβ1-40 peptide; Lane 3: 50 ng of the Aβ1-42 peptide; Lane 4: 50 ng of the recombinant human APP751 protein; Lane 5: 20µg of the human brain lysate; Lane 6: 50 ng of the rodent Aβ1-42 peptide. The blot was incubated with 1 µg/mL of the primary antibody overnight at 4°C, followed by incubation with the HRP goat anti-mouse IgG antibody (Cat. No. 405306). Enhanced chemiluminescence was used as the detection system.
  • A_6E10_PURE_betaAmyloid_1-16_WB_050818
    Western blot of purified anti-β-amyloid, 1-16 antibody (clone 6E10). Lane 1: Molecular weight marker; Lane 2: 50 ng of the human Aβ1-40 peptide; Lane 3: 50 ng of the Aβ1-42 peptide; Lane 4: 50 ng of the recombinant human APP751 protein; Lane 5: 20µg of the human brain lysate; Lane 6: 50 ng of the rodent Aβ1-42 peptide. The blot was incubated with 1 µg/mL of the primary antibody overnight at 4°C, followed by incubation with the HRP goat anti-mouse IgG antibody (Cat. No. 405306). Enhanced chemiluminescence was used as the detection system.
  • B_6E10_PURE_betaAmyloid_1-16_DirectELISA_050818
    Direct ELISA of purified anti-β-amyloid 1-16 (clone 6E10) antibody binding to the plate-immobilized human Aβ1-40 and the recombinant human APP751. ELISA was performed by coating the wells with 100 ng of peptide or recombinant protein. The wells were then incubated with the primary antibody at 37°C for 45 minutes, followed by incubation with HRP labeled goat anti-mouse IgG secondary antibody. TMB (3, 3', 5, 5' tetramethylbenzidine, Cat. No. 421501) was used as the detection system.
  • C_6E10_PURE_betaAmyloid_1-16_IHCP_050818
    IHC staining of purified anti-β-Amyloid, 1-16 antibody (clone 6E10) on the formalin-fixed paraffin-embedded normal human (left panel) and Alzheimer’s disease (right panel) brain tissues. Following antigen retrieval using 70% formic acid for 20 minutes, the tissues were incubated with 1µg/mL of the primary antibody for 1 hour at room temperature. BioLegend’s Ultra-Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The images were captured with a 40X objective. Scale bar: 50 µm
Cat # Size Price Quantity Avail. Save
803003 1 mL 1 519 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
803004 25 µL 95 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
803001 200 µL 472 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
803002 500 µL 923 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Alzheimer's disease is characterized by the accumulation of aggregated Aβ peptides in senile plaques and vascular deposits. Aβ peptides are derived from amyloid precursor proteins (APP) through sequential proteolytic cleavage of APP by β-secretases and γ-secretases generating diverse Aβ species. Aβ can aggregate to form soluble oligomeric species and insoluble fibrillar or amorphous assemblies. Some forms of the aggregated peptides are toxic to neurons.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution (no preservatives or carrier proteins).
Preparation
The antibody was purified by affinity chromatography.
Concentration
1 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check your vial or your CoA to find the most accurate storage condition for this antibody.
Application

WB - Quality tested
Direct ELISA, IHC-P Verified
IHC-F, EM, ICC -  Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by western blotting. For western blotting, the suggested use of this reagent is 1 µg/mL. For Direct ELISA, the suggested use of this reagent is 0.002 - 0.02 µg/mL. For immunohistochemistry on formalin-fixed paraffin-embedded tissue sections, the suggested use of this reagent is 0.2 - 5.0 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

This antibody is reactive to amino acid residue 1-16 of beta amyloid. The epitope lies within amino acids 3-8 of beta amyloid (EFRHDS).

This antibody clone has been reported for use in immunohistochemistry of free-floating sections2,13.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Thakker DR, et al. 2009. Proc. Natl. Acad. Sci. USA. 106(11):4501-6. (IHC) PubMed
  2. Oddo S, et al. 2005. Proc. Natl. Acad. Sci. USA. 102(8):3046-51. (IHC-other) PubMed
  3. Herzig M, et al. 2004. Nat. Neuro. 7(9):954-959. (WB) PubMed
  4. Zheng Y, et al. 2012. PLoS One 6:39035. (IHC-F) PubMed
  5. Abramowksi D, et al. J Neurosci. 32:1273. (WB) PubMed
  6. Forny-Germano L, et al. 2014. J. Neurosci. 34:13629. (WB, IHC) PubMed
  7. Gowert NS, et al. 2014. PLoS One 2:e90523. (ICC, EM) PubMed
  8. Sandoval-Hernández A, et al. 2015. PLoS One. 10: 0145467. (IHC-F)
  9. Kumar R, et al. 2016. Brain. 139:174-92 (WB)
  10. Miyamoto T, et al. 2016. J. Biol. Chem. 291:1719-34. (WB)
  11. Saito S, et al. 2017. Acta Neuropathol. Commun. 5:26-9. (IHC-P) PubMed
  12. Omata Y, et al. 2016. Aging (Albany NY) 8(3):427. (IHC-P) PubMed
  13. Peng W, et al. 2016. Neurobiol. Dis. 93:215. (IHC-other) PubMed
  14. Mandler M, et al. 2015. PLoS One. e0115237. (WB, IHC, ELISA) PubMed
Product Citations
  1. Willén K, et al. 2017. Mol Neurodegener. 10.1186/s13024-017-0203-y. PubMed
  2. Rocchi A, et al. 2017. PLoS Genet.. 10.1371/journal.pgen.1006962. PubMed
  3. Park J,et al. 2017. J Radiat Res.. 10.1093/jrr/rrx045. PubMed
  4. Zhi D, et al. 2017. Sci Rep. 10.1038/s41598-017-11628-9. PubMed
  5. Chen L, et al. 2017. Sci Rep. 10.1038/s41598-017-12484-3. PubMed
  6. Faraz A, et al. 2017. Antioxid Redox Signal. . 10.1089/ars.2016.6860. PubMed
  7. Casali BT, et al. 2018. J Neuroinflammation. 15:43. PubMed
  8. Matthes F, et al. 2018. Cell Death Discov. 4:4. PubMed
  9. Kim W, et al. 2018. Mol Neurodegener. 13:6. PubMed
  10. Aisling Chaney et al. 2017. Journal of neurochemistry. 144(3):318-335 . PubMed
  11. Datta M, et al. 2018. Immunity. 48:514. PubMed
  12. Ahmad F et al. 2018. Scientific reports. 8(1):13119 . PubMed
  13. Pan RY, et al. 2019. Sci Adv. 5:eaau6328. PubMed
  14. Chiang ACA, et al. 2018. Am J Pathol. 188:739. PubMed
  15. Hung COY et al. 2018. Cell reports. 25(13):3647-3660 . PubMed
  16. Kulas JA, et al. 2017. J Endocrinol. 235:49. PubMed
  17. Yang C, et al. 2017. Autophagy. :0. PubMed
  18. Bartolotti N, et al. 2018. J Alzheimers Dis. 66:1425. PubMed
  19. Sun J, et al. 2019. Nat Commun. 10:53. PubMed
  20. Limbocker R, et al. 2019. Nat Commun. 10:225. PubMed
  21. Leonetti M, et al. 2019. Sci Rep. 9:4591. PubMed
  22. Harach T, et al. 2017. Sci Rep. 7:41802. PubMed
  23. Poksay KS, et al. 2017. Front Pharmacol. 8:46. PubMed
  24. Xia F, et al. 2017. Neuropsychopharmacology. 42:2493. PubMed
  25. Wang X, et al. 2017. Front Aging Neurosci. 9:157. PubMed
  26. Chandramowlishwaran P, et al. 2018. J Biol Chem. 293:3436. PubMed
  27. Song M, et al. 2018. Genes (Basel). 9:. PubMed
  28. Dong ZZ, et al. 2018. Int J Ophthalmol. 11:747. PubMed
  29. Rosenzweig N, et al. 2019. Nat Commun. 10:465. PubMed
  30. Sri S, et al. 2019. Acta Neuropathol Commun. 7:25. PubMed
  31. Feng T, et al. 2017. J Biol Chem. 292:1679. PubMed
  32. Garcia–Esparcia P, et al. 2017. Front Neurol. 8:89. PubMed
  33. Lin TW, et al. 2017. PLoS One. 12:e0174561. PubMed
  34. Amar F, et al. 2017. Sci Signal. 10:478. PubMed
  35. López–Arias B, et al. 2017. PLoS One. 12:e0177541. PubMed
  36. Finke JM, et al. 2017. Biochim Biophys Acta. 1861:2228. PubMed
  37. Hu X, et al. 2017. Front Neuroanat. 11:45. PubMed
  38. Kedia N, et al. 2017. Phys Chem Chem Phys. 19:18036. PubMed
  39. Li N, et al. 2017. Curr Alzheimer Res. 14:1109. PubMed
  40. O'Reilly MA, et al. 2017. Theranostics. 7:3573. PubMed
  41. Welty S, et al. 2018. J Biol Chem. 293:1353. PubMed
  42. Ziegler–Waldkirch S, et al. 2018. EMBO J. 37:167. PubMed
  43. Ayaki T, et al. 2018. J Neuropathol Exp Neurol. 77:128. PubMed
  44. Lim CS, et al. 2018. Biosci Rep. 38:1. PubMed
  45. Söllvander S, et al. 2018. J Neuroinflammation. 15:98. PubMed
  46. Zhang JH, et al. 2018. BMC Complement Altern Med. 18:167. PubMed
  47. González C, et al. 2018. Mol Psychiatry. 23:2363. PubMed
  48. Fowler AJ, et al. 2019. Drugs R D. 19:149. PubMed
  49. Dyer M, et al. 2019. Front Aging Neurosci. 11:68. PubMed
  50. Xu L et al. 2019. Cell reports. 27(4):1293-1306 . PubMed
  51. Grant MKO, et al. 2019. Biol Proced Online. 21:6. PubMed
  52. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  53. Kiyota T, et al. 2018. J Neuroimmunol. 319:80. PubMed
  54. Chandra S, et al. 2019. J Alzheimers Dis Rep. 3:149. PubMed
  55. Gulisano W, et al. 2019. J Neurosci. 39:5986. PubMed
  56. Harper MM, et al. 2019. Invest Ophthalmol Vis Sci. 60:2716. PubMed
  57. Jonson M, et al. 2018. Cell Chem Biol. 25:595. PubMed
  58. Roitenberg N, et al. 2018. EMBO Rep. 19. PubMed
  59. Baek SH, et al. 2017. J Neurosci. 37:5099. PubMed
  60. Lisa Dolfe et al. 2018. Journal of Alzheimer's disease reports. 2(1):27-39 . PubMed
  61. Croft CL, et al. 2017. Cell Death Dis. 8:e2671. PubMed
  62. Valls–Comamala V, et al. 2017. Oncotarget. 8:41154. PubMed
  63. Paula PC, et al. 2019. Molecules. 24. PubMed
  64. Esposito G, et al. 2019. Mar Drugs. 17. PubMed
  65. Khan I, et al. 2018. Sci Rep. 8:12834. PubMed
  66. Bearer EL, et al. 2018. Neurobiol Aging. 70:276. PubMed
  67. Wendeln AC, et al. 2018. Nature. 556:332. PubMed
  68. Vargas–Restrepo F, et al. 2018. Biomedica. 38:69. PubMed
  69. Yadav DB, et al. 2017. Br J Pharmacol. 174:4173. PubMed
  70. Opazo P, et al. 2018. Cell Rep. 23:3137. PubMed
  71. Herzer S, et al. 2018. Front Mol Neurosci. 11:206. PubMed
  72. Plá V, et al. 2017. Front Mol Neurosci. 10:202. PubMed
  73. Spitzer P, et al. 2018. Front Aging Neurosci. 10:152. PubMed
  74. Serra–Batiste M, et al. 2018. Front Mol Biosci. 5:38. PubMed
  75. de Dios C, et al. 2019. Redox Biol. 26:101283. PubMed
  76. Merlini M et al. 2019. Neuron. 101(6):1099-1108 . PubMed
  77. Fiock KL et al. 2019. J Comp Neurol. 528(1):108-113 . PubMed
  78. Cecon E et al. 2019. Br J Pharmacol. 176(18):3475-3488 . PubMed
  79. Cline EN, et al. 2019. J Neurochem. 148:822. PubMed
  80. Abud EM et al. 2017. Neuron. 94(2):278-293 . PubMed
  81. Sebollela A et al. 2017. Journal of neurochemistry. 142(6):934-947 . PubMed
  82. Ye X et al. 2017. The Journal of Neuroscience. 37(10):2639-2655 . PubMed
  83. Huynh TV, et al. 2017. Neuron. 96:1013. PubMed
  84. Nobili A et al. 2017. Nature communications. 253:27:00 . PubMed
  85. Colvin BA, et al. 2017. J Neurochem. 143:736. PubMed
  86. Bove–Fenderson E, et al. 2017. J Biol Chem. 292:16858. PubMed
  87. Asam K, et al. 2017. PLoS One. 12:e0189413. PubMed
  88. Reinhardt S, et al. 2018. Sci Rep. 1.25625. PubMed
  89. Park JS, et al. 2018. Sensors (Basel). 18:00. PubMed
  90. Di Fede G, et al. 2018. Sci Rep. 2.603472222. PubMed
  91. Zhang L, et al. 2018. Neurobiol Dis. 114:01:00. PubMed
  92. Chandra S, et al. 2018. J Neurosci. 38:6682. PubMed
  93. Liu D, et al. 2018. Neurobiol Aging. 70:160. PubMed
  94. Chernick D, et al. 2018. J Neurochem. 147:647. PubMed
  95. Edler MK, et al. 2018. J Comp Neurol. 526:2921. PubMed
  96. Rubio–Araiz A, et al. 2018. J Neuroinflammation. 0.796527778. PubMed
  97. Kozin SA, et al. 2018. Front Neurosci. 0.859722222. PubMed
  98. Barykin EP, et al. 2018. Front Mol Neurosci. 0.668055556. PubMed
  99. Rosenberg RN, et al. 2018. Alzheimers Res Ther. 0.496527778. PubMed
  100. Keene CD, et al. 2019. Lab Invest. 99:1056. PubMed
  101. Stimmell AC, et al. 2019. Sci Rep. 1.285416667. PubMed
  102. Yang P, et al. 2019. BMC Immunol. 20:09. PubMed
  103. Braggin JE, et al. 2019. Ann Clin Transl Neurol. 0.779166667. PubMed
  104. Esquerda–Canals G, et al. 2019. PLoS One. 14:e0217793. PubMed
  105. Prakash P, et al. 2019. Methods Protoc. 2:48. PubMed
  106. Qin K, et al. 2019. Sci Rep. 6.294444444. PubMed
  107. Sheng L, et al. 2019. FASEB J. 33:10425. PubMed
  108. Li L, et al. 2019. Exp Neurobiol. 28:329. PubMed
  109. Shmueli MD, et al. 2017. J Biol Methods. 4:e69. PubMed
  110. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  111. Zysk M, et al. 2019. J Alzheimers Dis. 72:161. PubMed
  112. van Husen LS, et al. 2019. J Alzheimers Dis. 72:537. PubMed
  113. Hansson O, et al. 2019. Alzheimers Res Ther. 0.51875. PubMed
  114. Kollmer M, et al. 2019. Nat Commun. 3.722222222. PubMed
  115. Ding Y, et al. 2019. Front Neurol. 1.208333333. PubMed
  116. Cox LM, et al. 2019. Sci Rep. 9:17904. PubMed
  117. Pires G, et al. 2019. Acta Neuropathol Commun. 0.427083333. PubMed
  118. Beraldo FH, et al. 2019. Elife. 8:e49630. PubMed
  119. Lee HT, et al. 2019. J Neuroinflammation. 0.852083333. PubMed
  120. Medina CS, et al. 2019. Front Cell Neurosci. 0.889583333. PubMed
  121. Wang S, et al. 2019. Sci Rep. 9:19575. PubMed
  122. Hu T, et al. 2020. Aging (Albany NY). 0.834027778. PubMed
  123. Pi G, et al. 2020. Nat Commun. 0.585416667. PubMed
  124. Ren J, et al. 2020. Int J Clin Exp Pathol. 3.030555556. PubMed
  125. Yan T, et al. 2020. Nat Commun. 0.74375. PubMed
  126. Tambini MD, et al. 2020. Elife. 9:e52612. PubMed
  127. Fang EF, et al. 2019. Nat Neurosci. 22:401. PubMed
  128. Batarseh YS, et al. 2017. Neuroscience. 352:204. PubMed
  129. Sachdev R, et al. 2018. Mol Neurobiol. 55:8355. PubMed
  130. Kaya I, et al. 2017. ACS Chem Neurosci. 8:347. PubMed
  131. An Y, et al. 2020. Front Immunol. 11:162. PubMed
  132. Eede P, et al. 2020. EMBO Rep. 21:e48530. PubMed
  133. Zheng Y, et al. 2019. Brain. 142:787. PubMed
  134. Vu HT, et al. 2017. Sci Rep. 7:40205. PubMed
  135. Zhu X, et al. 2017. Aging Cell. 16:1073. PubMed
  136. Gerber H, et al. 2019. Acta Neuropathol Commun. 7:13. PubMed
  137. Yan T, et al. 2018. J Alzheimers Dis. 63:157. PubMed
  138. Imanikia S, et al. 2019. Cell Rep. 28:581. PubMed
  139. Imanikia S, et al. 2019. Curr Biol. 29:2322. PubMed
  140. Gee MS, et al. 2020. Alzheimers Res Ther. 12:45. PubMed
  141. Shi H, et al. 2020. Acta Neuropathol. 139:813. PubMed
  142. Bonds JA, et al. 2019. J Neurosci. 39:8576. PubMed
  143. Ren P, et al. 2020. Oxid Med Cell Longev. 2020:3050971. PubMed
  144. Calvo-Rodríguez M, et al. 2020. Nat Commun. 11:2146. PubMed
  145. Tambini MD, et al. 2020. J Biol Chem. 295:7442. PubMed
  146. Li S, et al. 2020. Front Immunol. 11:49. PubMed
  147. Chen X, et al. 2020. Nat Commun. 11:867. PubMed
  148. Schmidt K, et al. 2017. Mediators Inflamm. 2017:5470831. PubMed
  149. Buccarello L, et al. 2017. Oncotarget. 8:83038. PubMed
  150. Sogorb-Esteve A, et al. 2018. Mol Neurobiol. 55:5047. PubMed
  151. Pera M, et al. 2017. EMBO J. 36:3356. PubMed
  152. Brozzetti L, et al. 2020. Front Neurosci. 14:145. PubMed
  153. Wang D, et al. 2018. Neurosci Bull. 34:912. PubMed
  154. Van der Jeugd A, et al. 2018. Sci Rep. 8:6431. PubMed
  155. Readhead B, et al. 2018. Neuron. 99:64. PubMed
  156. Batarseh YS, et al. 2018. J Nutr Biochem. 55:113. PubMed
  157. Huichalaf CH, et al. 2019. Hum Mol Genet. 28:2014. PubMed
  158. Lahiri S, et al. 2019. Crit Care. 1.002083333. PubMed
  159. Baik SH, et al. 2020. Cell Metabolism. 30(3):493-507. PubMed
  160. Michno W, et al. 2020. Journal of Neurochemistry. 152(5):602-616.. PubMed
  161. Bai B, et al. 2020. Neuron. 105(6):975-991.e7.. PubMed
  162. Ghatak S, et al. 2020. eLife. 8:e50333.. PubMed
  163. Socodato R, et al. 2020. Cell Reports. 31(12):107796. PubMed
  164. Griner SL, et al. 2020. eLife. 8:e46924.. PubMed
  165. Shippy DC, et al. 2020. J Neuroinflammation. 0.902777778. PubMed
  166. Yao J, et al. 2020. Cell Rep. 32:108169. PubMed
  167. Li L, et al. 2020. Neural Plast. 2020:8836173. PubMed
  168. Goodman JR, et al. 2018. Brain Behav Immun. 73:34:00. PubMed
  169. Turnbull MT, et al. 2018. Front Mol Neurosci. 11:51. PubMed
  170. Sandoval-Hernández A, et al. 2015. PLoS One. 10: 0145467. PubMed
  171. Kumar R, et al. 2016. Brain. 139: 174 - 192. PubMed
  172. Miyamoto T, et al. 2016. J Biol Chem. 291: 1719 - 1734. PubMed
  173. Baruch K, et al. 2016. Nat Med. 22:135-137. PubMed
  174. Fu A, et al. 2016. Proc Natl Acad Sci U S A. 113: 2705 - 2713. PubMed
  175. Donner L, et al. 2016. Sci Signal. 9: ra52. PubMed
  176. Cifelli J, et al. 2016. J Biol Chem. 291: 11981 - 11992. PubMed
  177. Hernandez-Rapp J, et al. 2016. Sci Rep. 6:30953. PubMed
  178. Pan H, et al. 2016. Stem Cell Reports. 7:707-718. PubMed
  179. Salta E, et al. 2016. EMBO Mol Med. 8: 1005 - 1018. PubMed
  180. Sherman M, et al. 2016. J Neurosci. 36: 9647 - 9658. PubMed
  181. Reinders N, et al. 2016. Proc Natl Acad Sci U S A. 113: E6526 - E6534. PubMed
  182. Hostetler E, et al. 2016. J Nucl Med. 57: 1599 - 1606. PubMed
  183. A Kimura, S Hata, T Suzuki 2016. J Biol Chem. 291: 24041 - 24053. PubMed
  184. Daria A, et al. 2017. EMBO J. 10.15252/embj.201694591. PubMed
  185. Flanagan M, et al. 2017. J Neuropathol Exp Neurol. 10.1093/jnen/nlw104. PubMed
  186. Yang S, et al. 2017. EMBO Mol Med. 9(1):61-77. PubMed
  187. Augé E, et al. 2017. Sci Rep. 7:41807. PubMed
  188. Kirouac L et al. 2015. eNeuro. 4(2) pii: ENEURO. PubMed
RRID
AB_2564652 (BioLegend Cat. No. 803003)
AB_2715854 (BioLegend Cat. No. 803004)
AB_2564653 (BioLegend Cat. No. 803001)
AB_2564654 (BioLegend Cat. No. 803002)

Antigen Details

Structure
Amyloid precursor protein is a 770 amino acid protein with a molecular mass of ~100 kD. According to the UniProtKB database, APP (ID# P05067) has 11 isoforms (34 to ~90 kD) and the 770 form has been designated as the canonical form. Isoform APP695 is the predominant form expressed in neuronal tissue. Isoforms APP751 and APP770 are widely expressed in non-neuronal cells. Isoform APP751 is the most abundant form in T-lymphocytes. Aβ denotes peptides of 36-43 amino acids generated from cleavage of APP by secretases. Aβ has an apparent molecular mass of about 4 kD.
Distribution

Tissue distribution: Primarily nervous system, but also adipose tissue, intestine, muscle.
Cellular distribution: Cytosol, endosomes, nucleus, plasma membrane, extracellular, and golgi apparatus.

Function
The normal function of Aβ is not well understood. Several potential physiological roles have been proposed, including: activation of kinase enzymes; protection against oxidative stress; regulation of cholesterol transport; transcription factor, and as an anti-microbial agent.
Biology Area
Cell Biology, Neurodegeneration, Neuroscience, Protein Misfolding and Aggregation
Molecular Family
APP/β-Amyloid
Antigen References
  1. Kumar A, et al. 2015. Pharmacol. Rep. 67(2):195.
  2. Sadigh-Eteghad S, et al. 2015. Med. Princ. Pract. 24(1):1
  3. Hampel H, et al. 2015. Expert Rev. Neurother. 15(1):83.
  4. Puig KL, et al. 2012.  Exp. Gerontol. 48(7): 608.
  5. Selkoe DJ, et al. 2016. EMBO Mol. Med. 8(6):595.
  6. Walsh DM, et al.  2007. J. Neurochem. 101(5):1172.
Gene ID
351 View all products for this Gene ID
UniProt
View information about beta-Amyloid, 1-16 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 03.12.2021

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account